NCT02029144

Observational Study of Dydrogesterone in Cycle Regularization

Dydrogesterone in Cycle Regularization in Abnormal Uterine Bleeding - Ovulation Dysfunction (AUB-O) Patients: A Prospective, Observational Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 114 (actual)
• Sponsor: Fudan University · Academic / Other
• Sex: Female
• Age: 16 Years
• Healthy volunteers: Not accepted

Summary

Dydrogesterone has been widely used worldwide for various gynecological and obstetric indications: * Dydrogesterone is effective in cycle regulation treatment. * Dydrogesterone is recognized as none interference to hypothalamus pituitary ovary (HPO) axis in the recommended dosage. * Dydrogesterone might have non-negative effect on glucose and lipid metabolic.

Detailed description

The current study is designed as a prospective, non-interventional, observational study. Patients with irregular cycle diagnosed as AUB-O will be prescribed dydrogesterone as per physician's clinical practice.

Conditions

• Observational Study
• Dydrogesterone
• Irregular Menstrual Cycle
• Abnormal Uterine Bleeding

Timeline

• Start date: 2013-12-01
• Primary completion: 2015-02-01
• Completion: 2015-02-01
• First posted: 2014-01-07
• Last updated: 2015-02-10

Locations

1 site across 1 country: China